Table 1 Clinical characteristics of patients
From: Endothelial progenitor cells display clonal restriction in multiple myeloma
Case Number | Age/Sex | Source of EPC | %Plasma Cells in BM† | M protein (g/dL) | β2-microglobulin (mg/L) | Albumin (mg/mL) | Durie/Salmon Stage | Cytogenetics‡ |
|---|---|---|---|---|---|---|---|---|
1 | 53/F | PBMC | 10 | 1.2, IgG κ | 1.6 | 2.3 | 2A | ND |
2 | 62/F | PBMC | 30 | 1.2, IgG λ | 1.8 | 3.5 | 2A | Normal |
3 | 60/F | PBMC | 40 | 2.4, IgG κ | 2.2 | 4.0 | 2A | ND |
4 | 70/F | PBMC | 80 | 6.0 IgG κ | 3.0 | 3.5 | 3A | ND |
5 | 54/F | PBMC | 15 | 1.1, IgG κ | 6.8 | 2.4 | 2A | ND |
6 | 55/F | BM | 10 | 3.0, IgG κ | 2.0 | 3.4 | 2A | Normal |
7 | 50/F | PBMC | 30 | 4.8, IgG κ | 4.6 | 3.7 | 3A◆ | ND |
8 | 46/F | PBMC | 10 | 2.8, κ LC | 4.9 | 3.9 | 3A | ND |
9 | 52/F | BM | 5 | 1.1, IgG κ | 2.6 | 4.0 | 1A | ND |
10 | 56/F | PBMC | 30 | 2.0, λ LC | 1.4 | 4.2 | 3A | ND |
11 | 73/F | BM | 10 | 3.0, IgG κ | 2.4 | 3.8 | 1A | Normal |
12 | 66/M | BM | 10 | 3.0, IgG κ | 2.0 | 4.1 | 1A | ND |
13 | 56/F | BM | 95 | 7.0, IgG κ | 3.7 | 3.2 | 3A | Normal |
14 | 54/F | BM | 90 | 2.9, IgG λ | 1.8 | 4.0 | 2A | ND |
15 | 53/M | BM | 95 | 3.6, IgA κ | 3.0 | 3.0 | 3A | Normal |
16 | 66/F | BM | 60 | 5.4, IgA λ | 3.5 | 1.9 | 3A | Normal |